Additionally, early-onset PD patients with mutations in two genes encoding for parkins (PARK2 and PARK2), or mice lacking a mitochondrial serine/threonine protein kinase (PINK1) showed an exacerbated NLRP3 inflammasome response in their microglia and macrophages (239). This evidence concerns the gene NLRP3 and Parkinson disease.